Production (Stage)
Emmaus Life Sciences, Inc.
EMMA
$0.017
$0.000.00%
OTC PK
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 46.41% | -244.58% | 2,626.87% | -40.18% | -25.99% |
| Total Depreciation and Amortization | -16.67% | -16.67% | -37.50% | -33.33% | -33.33% |
| Total Amortization of Deferred Charges | -79.96% | -89.43% | -88.16% | -89.91% | -15.12% |
| Total Other Non-Cash Items | 437.50% | 58.31% | -8.89% | -42.34% | -102.02% |
| Change in Net Operating Assets | -41.95% | 237.89% | -84.54% | 27.70% | 597.04% |
| Cash from Operations | 99.29% | -66.89% | 155.17% | -123.52% | 110.84% |
| Capital Expenditure | -- | 0.00% | -- | 40.00% | 33.33% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | 100.00% | 134.61% | -- |
| Cash from Investing | -- | 66.67% | 100.25% | 135.43% | 99.63% |
| Total Debt Issued | -13.86% | -55.48% | -81.19% | 3.30% | -48.36% |
| Total Debt Repaid | 34.14% | 46.07% | 67.07% | 31.73% | -313.16% |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 63.87% | -3,800.00% | -188.66% | 253.59% | -144.61% |
| Foreign Exchange rate Adjustments | 162.50% | -170.59% | 311.11% | 47.37% | -220.00% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 93.29% | -87.14% | -287.50% | 54.72% | -238.06% |